Bank Of America Corp Global Blood Therapeutics, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $6.32 Million - $13.3 Million	-195,044 Reduced 56.67%	149,118 $10.2 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $32.8 Million - $55.1 Million	-1,473,025 Reduced 81.06%	344,162 $11 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $6.7 Million - $9.28 Million	260,871 Added 16.76%	1,817,187 $62.9 Million
Q4 2021 Feb 08, 2022	SELL	$24.9 - $40.26 $6.28 Million - $10.2 Million	-252,341 Reduced 13.95%	1,556,316 $45.6 Million
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $110 Million - $162 Million	-4,326,789 Reduced 70.52%	1,808,657 $46.1 Million
Q2 2021 Sep 13, 2021	BUY	$32.46 - $43.42 $199 Million - $266 Million	6,135,446 New	6,135,446 $215 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.